Palisade Bio Inc. [NASDAQ: PALI] slipped around -1.04 points on Monday, while shares priced at $6.57 at the close of the session, down -13.67%.
Palisade Bio Inc. stock is now 24.43% up from its year-to-date (YTD) trading value. PALI Stock saw the intraday high of $8.66 and lowest of $6.52 per share. The company’s 52-week high price is 16.02, which means current price is +25.86% above from all time high which was touched on 03/22/21.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Compared to the average trading volume of 583.02K shares, PALI reached a trading volume of 1081476 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Palisade Bio Inc. [PALI]?
The Average True Range (ATR) for Palisade Bio Inc. is set at 1.25 The Price to Book ratio for the last quarter was 1.94, with the Price to Cash per share for the same quarter was set at 1.40.
How has PALI stock performed recently?
Palisade Bio Inc. [PALI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -34.82. With this latest performance, PALI shares dropped by -35.21% in over the last four-week period, additionally plugging by 88.83% over the last 6 months – not to mention a rise of 58.70% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PALI stock in for the last two-week period is set at 33.94, with the RSI for the last a single of trading hit 26.97, and the three-weeks RSI is set at 38.63 for Palisade Bio Inc. [PALI]. The present Moving Average for the last 50 days of trading for this stock 9.20, while it was recorded at 8.44 for the last single week of trading, and 6.17 for the last 200 days.
Palisade Bio Inc. [PALI]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Palisade Bio Inc. [PALI] shares currently have an operating margin of -78961.14. Palisade Bio Inc.’s Net Margin is presently recorded at -120316.72.
Return on Total Capital for PALI is now -141.63, given the latest momentum, and Return on Invested Capital for the company is -216.28. Return on Equity for this stock declined to -218.44, with Return on Assets sitting at -165.71.
Reflecting on the efficiency of the workforce at the company, Palisade Bio Inc. [PALI] managed to generate an average of -$2,323,831 per employee. Receivables Turnover for the company is 0.20 with a Total Asset Turnover recorded at a value of 0.00.Palisade Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.00 and a Current Ratio set at 4.00.
Insider trade positions for Palisade Bio Inc. [PALI]
There are presently around $1 million, or 5.40% of PALI stock, in the hands of institutional investors. The top three institutional holders of PALI stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 27,919, which is approximately -35.776% of the company’s market cap and around 0.32% of the total institutional ownership; VIRTU FINANCIAL LLC, holding 20,593 shares of the stock with an approximate value of $0.16 million in PALI stocks shares; and HIGHTOWER ADVISORS, LLC, currently with $0.13 million in PALI stock with ownership of nearly -33.355% of the company’s market capitalization.
Positions in Palisade Bio Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 9 institutional holders increased their position in Palisade Bio Inc. [NASDAQ:PALI] by around 30,700 shares. Additionally, 4 investors decreased positions by around 89,487 shares, while 7 investors held positions by with 27,953 shares. The mentioned changes placed institutional holdings at 92,234 shares, according to the latest SEC report filing. PALI stock had 3 new institutional investments in for a total of 9,236 shares, while 1 institutional investors sold positions of 65,570 shares during the same period.